[Research progress on ferroptosis regulation in tumor immunity of hepatocellular carcinoma]. [PDF]
Mo Y, Zou Z, Chen E.
europepmc +1 more source
[Expression of YARS1 in hepatocellular carcinoma and its prognostic effect]. [PDF]
Hu LH +9 more
europepmc +1 more source
Role of miR-5010-3p in predicting the prognosis of hepatocellular carcinoma. [PDF]
Cao Z, Zeng L, Wang Z, Zhou Y, Qian K.
europepmc +1 more source
目的: 研究小鼠 B7 修饰的肿瘤细胞疫苗的体内外抗肿瘤作用。 方法: 应用逆转录病毒载体, 将小鼠 B 7-1 和 B7-2 导入小鼠肝癌细胞 Hepal-6细胞株中, G418 筛选后获高表达 B7 分子的阳性细胞克隆,经丝裂霉素处理制备成肿瘤细胞 疫苗( TCV) ,观察 TCVB7体外刺激的脾细胞对不同肿瘤细胞系的抗瘤活性及对不同动物模型的体内免疫保护作用和免疫治疗 作用。结果: ①TCVB7体外刺激的脾细胞对亲本肝癌细胞和小鼠 NK 敏感的 Yac-1细胞的体外细胞毒作用明显增强; ②在免疫 ...
doaj
[Overexpression of parathyroid hormone-like hormone facilitates hepatocellular carcinoma progression and correlates with adverse outcomes]. [PDF]
Miao X +9 more
europepmc +1 more source
【目的】 探讨硒化麒麟菜多糖在体外对肝癌HepG2.2.15细胞株生长和凋亡的作用及机制?【方法】 处于生长期的人肝癌细胞HepG2.2.15分为3组,对照组?硒化麒麟菜多糖组和顺氨氯铂组?用MTT法检测各组肿瘤细胞增殖的情况,流式细胞仪检测细胞周期?细胞调亡以及凋亡基因Fas的表达情况?【结果】 硒化麒麟菜多糖在体外可抑制肿瘤细胞的增殖,最高抑制率为97.2%,并且有时间依赖性?硒化麒麟菜多糖可阻滞肝癌HepG2.2.15细胞的生长使之停留在S和G2/M期,从而抑制了肿瘤细胞的增殖 ...
doaj
[Current status and prospects for screening early-stage hepatocellular carcinoma]. [PDF]
Song HL +5 more
europepmc +1 more source
[Research advances in occurrence risk assessment and early-stage diagnosis of hepatocellular carcinoma]. [PDF]
Li YJ, Li JF, Chen Y.
europepmc +1 more source
[Multidisciplinary experts consensus on diagnosis and treatment of precancerous lesions of hepatocellular carcinoma (2023 version)]. [PDF]
Liver Cancer Study Group +3 more
europepmc +1 more source
[Research progress and clinical application in the early diagnosis and treatment technology of hepatocellular carcinoma]. [PDF]
Nan YM, Zhao SX, Liu LD.
europepmc +1 more source

